2 Excellent Healthcare Stocks to Hold Through the Next Decade
Although excellent medical care is always in high demand, the healthcare sector continuously evolves. Companies aren't ...
Leerink Partners Sticks to Its Buy Rating for Dexcom (DXCM)
Leerink Partners analyst Mike Kratky maintained a Buy rating on Dexcom (DXCM – Research Report) on November 25 and set a price target of ...
DexCom, Inc.'s (NASDAQ:DXCM) Intrinsic Value Is Potentially 59% Above Its Share Price
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...
Leerink Partnrs Has Positive Outlook of DexCom Q4 Earnings
Investment analysts at Leerink Partnrs lifted their Q4 2024 earnings per share estimates for shares of DexCom in a note ...
Why Is DexCom, Inc. (DXCM) Among the Worst Performing Healthcare Stocks in 2024?
We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a ...
These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
Through Nov. 22, the Nasdaq-100 is up over 23%, which is impressive for a broad index. However, it hasn't been peachy keen ...
DexCom, Inc. (DXCM): Innovation and Growth Catalysts Amid Strong Long-Term Outlook for Diabetes Care
We recently compiled a list of the Wells Fargo’s Best Growth Stocks: 28 Stocks With The Highest Consensus EPS Growth ...
Dexcom’s G7 Hospital CGM Poised for Market Breakthrough with NTAP and FDA Approvals
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price ...
Business Insider3d
Bank of America Securities Reaffirms Their Buy Rating on Dexcom (DXCM)
Bank of America Securities analyst Travis Steed maintained a Buy rating on Dexcom (DXCM – Research Report) today. The company’s shares opened today at $74.85. Don't Miss our Black Friday Offers: Steed ...
2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest
More impressive was Revolve Group's net income. Its bottom line was just shy of $11 million for the quarter. That was a 238% increase from the prior-year period, a time when it was also dealing with ...
Here’s Why DexCom (DXCM) Declined In Q3
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third quarter ...
DexCom, Inc. (NASDAQ:DXCM) Receives $104.59 Average Target Price from Analysts
Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eighteen analysts that are covering the stock, Marketbeat reports. Six equities ...